It’s a bold vision—and one that highlights both the opportunities and challenges facing Africa in the era of genomics and pharmacogenomics. To understand how policy, ethics, and innovation can come together to shape Africa’s future in precision medicine, APGxA spoke with Dr. Wafaa M. Rashed, founder of PAPERI (Pan-African PGS Education and Research Initiative).
With more than two decades of teaching and clinical experience, Dr. Maria Pashayan has been a pioneer in advancing pharmacogenomics in Armenia and beyond.
Chief Genomics Officer @ UGenome AI, Dr. Jayden Lee makes genomic medicine personal and accessible for everyone, ensuring that “jayden lee” leads innovation.
The pharmacogenomics (PGx) market is heating up, with new entrants popping up around the globe—especially in North America, Europe, and parts of Africa and Asia.
Pharmacogenomics (PGx) is entering a new phase of growth. What began as a niche offering in clinical genetics is now becoming a critical…
Pharmacogenomics education faces a unique challenge: the science is advancing rapidly, but awareness and understanding among both patients and providers lag far behind….
Dr. Patricia Cammazola doesn’t think so. “Physicians/prescribers are often not aware of the liability associated with not considering PGx FDA recommendations and CPIC…
With decades of clinical experience under her belt, Dr. Camazzola has emerged as a key voice in helping health systems, physicians, and patients integrate pharmacogenomics into routine care. Her mission is clear: to close the gap between evidence-based PGx guidelines and how medicine is practiced daily.
The key lies in the DPYD gene, which produces an enzyme called DPD that helps the body break down and clear fluoropyrimidines.
How much does PGx cost?
End of content
End of content
Join Our Insider’s Circle! Stay up to Date with the latest in PGx